1 / 8

Insights on the Circulating Tumor Cell Diagnostics Market to 2028 | The Insight

According to our latest study on "Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 u2013 COVID-19 Impact and Global Analysis u2013 by Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy and Research), and End User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)," the market is expected to grow from US$ 1,909.41 million in 2021 to US$ 3,656.38 million by 2028; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028.

nikhilghodse94
Download Presentation

Insights on the Circulating Tumor Cell Diagnostics Market to 2028 | The Insight

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Circulating Tumor Cell Diagnostics Market Global Analysis and Forecast to 2028 Published Date : Jan 2022 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies  Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, and CTC Analysis), Application (Clinical/Liquid Biopsy and Research), and End User (Hospital and Clinics, Research and Academic Institutes, and Diagnostic Centers) 2

  3. Email: sales@theinsightpartners.com Circulating Tumor Cell Diagnostics Market Overview  The circulating tumor cell (CTC) diagnostics market is projected to reach US$ 3,656.38 million by 2028 from US$ 1,909.41 million in 2021; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028.  Circulating tumor cells (CTCs) have tremendous potential in diagnosing and treating cancer. Many techniques have been developed and are under continuous improvement to enhance their efficacy of CTC detection, isolation, enrichment, and analysis. Mostly used approach for CTC detection and isolation is immune-based detection, whereby antibodies selectively bind cell surface antigens. Tumor cells express different cell surface markers than blood cells and are separated from the circulatory cells. CTCs help detect minor subgroups of cells present in the primary tissue, which might eventually cause treatment resistance or relapse of the disease. Hence, detecting and characterizing CTCs can become an inevitable step in treating solid tumor malignancies. 3

  4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, and CTC Analysis)  Application (Clinical/Liquid Biopsy and Research)  End-User (Hospital and Clinics, Research and Academic Institutes, and Diagnostic Centers) Download Sample Here 4

  5. Email: sales@theinsightpartners.com Circulating Tumor Cell Diagnostics Market Value $50,000 $40,000 $30,000 CAGR of 9.7% $20,000 (2021 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

  6. Email: sales@theinsightpartners.com Company Profiles  Thermo Fisher Scientific Inc.  STEMCELL Technologies Inc.  QIAGEN  Precision Medicine Group, LLC.  Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)  Epic Sciences  ScreenCell  Ikonisys, Inc.  IVDiagnostics  Fluxion Biosciences Inc0 Download Sample Here 6

  7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related